{"canonical":"https://abierto.us/vendors/phoenix-pharmaceuticals-inc-p8xlc937aak3","key":"P8XLC937AAK3","name":"PHOENIX PHARMACEUTICALS, INC.","uei":"P8XLC937AAK3","city":"BURLINGAME","state":"CA","awards":2,"obligated":"0","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541711","cage":"3F7E4","parent_name":"PHOENIX PHARMACEUTICALS, INC.","also_known_as":[],"country":"USA","actions":4,"first_action":"2024-05-21","last_action":"2026-06-03","breakdowns":{"naics":[{"key":"541711","name":null,"awards":1,"obligated":"0.00"},{"key":"541714","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"0.00"}],"product_service_codes":[{"key":"6505","name":null,"awards":2,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_IDV_75N98024A00126_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N98024A00126_7529/","piid":"75N98024A00126","parent_piid":null,"award_type":null,"vendor_key":"P8XLC937AAK3","recipient_name":"PHOENIX PHARMACEUTICALS, INC.","recipient_uei":"P8XLC937AAK3","recipient_cage":"3F7E4","recipient_city":"BURLINGAME","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","office_key":"o-75N980","first_action_date":"2024-05-21","last_action_date":"2026-06-03","actions":3,"obligated":"0","current_total_value":null,"potential_total_value":"10000000.00","naics":"541714","psc":"6505","extent_competed":null,"set_aside":null,"offers_received":null,"description":"BIOLOGICAL MATERIALS, BLOOD/BLOOD PRODUCTS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_HHSN263201500107B_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_HHSN263201500107B_7529/","piid":"HHSN263201500107B","parent_piid":null,"award_type":null,"vendor_key":"P8XLC937AAK3","recipient_name":"PHOENIX PHARMACEUTICALS, INC.","recipient_uei":"P8XLC937AAK3","recipient_cage":"3F7E4","recipient_city":"BURLINGAME","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH OLAO","office_key":"o-75N980","first_action_date":"2024-05-22","last_action_date":"2024-05-22","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"0","naics":"541711","psc":"6505","extent_competed":null,"set_aside":null,"offers_received":null,"description":"BIOLOGICAL MATERIALS, BLOOD/BLOOD PRODUCTS","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}